rs41278630

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 3P and 16B. PM1PP2BP4_StrongBP6_Very_StrongBS2

The NM_014874.4(MFN2):​c.892G>A​(p.Gly298Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00386 in 1,614,002 control chromosomes in the GnomAD database, including 18 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0022 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0040 ( 17 hom. )

Consequence

MFN2
NM_014874.4 missense

Scores

1
5
13

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:15

Conservation

PhyloP100: 1.91
Variant links:
Genes affected
MFN2 (HGNC:16877): (mitofusin 2) This gene encodes a mitochondrial membrane protein that participates in mitochondrial fusion and contributes to the maintenance and operation of the mitochondrial network. This protein is involved in the regulation of vascular smooth muscle cell proliferation, and it may play a role in the pathophysiology of obesity. Mutations in this gene cause Charcot-Marie-Tooth disease type 2A2, and hereditary motor and sensory neuropathy VI, which are both disorders of the peripheral nervous system. Defects in this gene have also been associated with early-onset stroke. Two transcript variants encoding the same protein have been identified. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 7 uncertain in NM_014874.4
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), MFN2. . Gene score misZ 1.6575 (greater than the threshold 3.09). Trascript score misZ 3.2174 (greater than threshold 3.09). GenCC has associacion of gene with Charcot-Marie-Tooth disease type 2A2, axonal hereditary motor and sensory neuropathy, hereditary motor and sensory neuropathy type 6, Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;, multiple symmetric lipomatosis, severe early-onset axonal neuropathy due to MFN2 deficiency.
BP4
Computational evidence support a benign effect (MetaRNN=0.011096537).
BP6
Variant 1-12001476-G-A is Benign according to our data. Variant chr1-12001476-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 199133.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-12001476-G-A is described in Lovd as [Pathogenic]. Variant chr1-12001476-G-A is described in Lovd as [Benign]. Variant chr1-12001476-G-A is described in Lovd as [Likely_benign].
BS2
High Homozygotes in GnomAdExome4 at 17 SD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
MFN2NM_014874.4 linkuse as main transcriptc.892G>A p.Gly298Arg missense_variant 9/19 ENST00000235329.10

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
MFN2ENST00000235329.10 linkuse as main transcriptc.892G>A p.Gly298Arg missense_variant 9/191 NM_014874.4 P1O95140-1

Frequencies

GnomAD3 genomes
AF:
0.00216
AC:
329
AN:
152202
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000651
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000851
Gnomad ASJ
AF:
0.00576
Gnomad EAS
AF:
0.000770
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000565
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00376
Gnomad OTH
AF:
0.00144
GnomAD3 exomes
AF:
0.00212
AC:
533
AN:
250848
Hom.:
0
AF XY:
0.00216
AC XY:
293
AN XY:
135596
show subpopulations
Gnomad AFR exome
AF:
0.000247
Gnomad AMR exome
AF:
0.00122
Gnomad ASJ exome
AF:
0.00477
Gnomad EAS exome
AF:
0.000599
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00106
Gnomad NFE exome
AF:
0.00347
Gnomad OTH exome
AF:
0.00196
GnomAD4 exome
AF:
0.00403
AC:
5896
AN:
1461682
Hom.:
17
Cov.:
32
AF XY:
0.00386
AC XY:
2807
AN XY:
727118
show subpopulations
Gnomad4 AFR exome
AF:
0.000538
Gnomad4 AMR exome
AF:
0.00119
Gnomad4 ASJ exome
AF:
0.00463
Gnomad4 EAS exome
AF:
0.000126
Gnomad4 SAS exome
AF:
0.0000116
Gnomad4 FIN exome
AF:
0.000936
Gnomad4 NFE exome
AF:
0.00485
Gnomad4 OTH exome
AF:
0.00422
GnomAD4 genome
AF:
0.00216
AC:
329
AN:
152320
Hom.:
1
Cov.:
33
AF XY:
0.00192
AC XY:
143
AN XY:
74486
show subpopulations
Gnomad4 AFR
AF:
0.000649
Gnomad4 AMR
AF:
0.000850
Gnomad4 ASJ
AF:
0.00576
Gnomad4 EAS
AF:
0.000771
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.000565
Gnomad4 NFE
AF:
0.00376
Gnomad4 OTH
AF:
0.00142
Alfa
AF:
0.00351
Hom.:
5
Bravo
AF:
0.00236
TwinsUK
AF:
0.00647
AC:
24
ALSPAC
AF:
0.00493
AC:
19
ESP6500AA
AF:
0.000681
AC:
3
ESP6500EA
AF:
0.00512
AC:
44
ExAC
AF:
0.00205
AC:
249
EpiCase
AF:
0.00311
EpiControl
AF:
0.00350

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:15
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Likely benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Likely benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Dec 02, 2014- -
not provided Benign:4
Likely benign, criteria provided, single submitterclinical testingGeneDxJun 07, 2021This variant is associated with the following publications: (PMID: 27582484, 26143526, 16043786, 24450158, 22492563, 19889647) -
Likely benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesMar 04, 2022- -
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenApr 01, 2024MFN2: BS1 -
Charcot-Marie-Tooth disease type 2 Benign:2
Benign, criteria provided, single submitterclinical testingInvitaeJan 30, 2024- -
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
Charcot-Marie-Tooth disease Benign:1
Likely benign, criteria provided, single submitterclinical testingMolecular Genetics Laboratory, London Health Sciences Centre-- -
Charcot-Marie-Tooth disease type 2A2 Benign:1
Likely benign, criteria provided, single submitterclinical testingMendelicsMay 28, 2019- -
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsSep 17, 2019This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Hereditary motor and sensory neuropathy with optic atrophy Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;;C4721887:Charcot-Marie-Tooth disease type 2A2;CN305336:Neuropathy, hereditary motor and sensory, type 6A Benign:1
Likely benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsNov 21, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.012
T
BayesDel_noAF
Pathogenic
0.21
CADD
Benign
23
DANN
Benign
0.93
DEOGEN2
Benign
0.12
T;T
Eigen
Benign
-0.32
Eigen_PC
Benign
-0.13
FATHMM_MKL
Uncertain
0.83
D
LIST_S2
Benign
0.85
D;.
M_CAP
Uncertain
0.14
D
MetaRNN
Benign
0.011
T;T
MetaSVM
Uncertain
0.0051
D
MutationAssessor
Benign
-0.90
N;N
MutationTaster
Benign
1.0
D;D;D
PrimateAI
Uncertain
0.68
T
PROVEAN
Benign
0.47
N;N
REVEL
Uncertain
0.53
Sift
Benign
0.46
T;T
Sift4G
Benign
0.51
T;T
Polyphen
0.0
B;B
Vest4
0.37
MutPred
0.78
Gain of sheet (P = 0.0221);Gain of sheet (P = 0.0221);
MVP
0.99
MPC
1.2
ClinPred
0.017
T
GERP RS
5.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.8
Varity_R
0.15
gMVP
0.79

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs41278630; hg19: chr1-12061533; API